What is ApolloMD?
ApolloMD operates as a fully-integrated national group practice, providing essential physician services across Emergency Medicine, Hospital Medicine, Anesthesia, and Radiology. With a footprint spanning over 100 healthcare institutions, the company distinguishes itself through a unique physician-ownership model and a performance-based compensation structure. Central to its operational efficiency is the CareHub Technology Suite, a proprietary platform designed to optimize patient engagement, streamline communication, and improve clinical outcomes. This combination of human capital and technological infrastructure has enabled ApolloMD to maintain a consistent growth rate for nearly three decades, positioning it as a critical partner for hospitals seeking to improve value-based care metrics.
How much funding has ApolloMD raised?
ApolloMD has raised a total of $3.9M across 2 funding rounds:
Private Equity
$3.2M
Private Equity
$718K
Private Equity (2015): $3.2M, investors not publicly disclosed
Private Equity (2016): $718K, investors not publicly disclosed
Key Investors in ApolloMD
Undisclosed Investor
An institutional capital partner focused on scaling large-scale healthcare service providers through long-term equity investment.
Undisclosed Investor
A private equity firm specializing in the growth and operational optimization of national multi-specialty medical groups.
Undisclosed Investor
A strategic investment entity providing the necessary capital for enterprise-level healthcare infrastructure and technology development.
What's next for ApolloMD?
With the recent influx of capital, ApolloMD is well-positioned to accelerate its expansion into new regional markets and further enhance its CareHub Technology Suite. The strategic focus will likely shift toward deepening its integration with existing hospital partners while exploring new avenues for multi-specialty service delivery. As the healthcare sector moves toward more coordinated, value-based care models, ApolloMD's ability to align physician incentives with institutional goals provides a significant competitive advantage. Future growth will likely be driven by continued investment in data-driven clinical workflows and the potential for further consolidation within the physician services market, ensuring the firm remains at the forefront of medical practice management.
See full ApolloMD company page
